Rani Therapeutics Holdings Inc (NASDAQ: RANI) established initial surge of 15.59% at $0.56, as the Stock market unbolted on Wednesday, before settling in for the price of $0.48 at the close. Taking a more long-term approach, RANI posted a 52-week range of $0.46-$6.38.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 67.06% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 4.78%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.00%. This publicly-traded company’s shares outstanding now amounts to $33.57 million, simultaneously with a float of $22.79 million. The organization now has a market capitalization sitting at $32.04 million. At the time of writing, stock’s 50-day Moving Average stood at $1.2173, while the 200-day Moving Average is $1.8688.
Rani Therapeutics Holdings Inc (RANI) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Rani Therapeutics Holdings Inc industry. Rani Therapeutics Holdings Inc’s current insider ownership accounts for 32.12%, in contrast to 8.76% institutional ownership. According to the most recent insider trade that took place on Dec 13 ’24, this organization’s Chief Business Officer bought 17,960 shares at the rate of 1.67, making the entire transaction reach 29,993 in total value, affecting insider ownership by 17,960. Preceding that transaction, on Dec 09 ’24, Company’s Chief Executive Officer bought 10,296 for 1.94, making the whole transaction’s value amount to 19,974. This particular insider is now the holder of 494,751 in total.
Rani Therapeutics Holdings Inc (RANI) Earnings and Revenue Records
Rani Therapeutics Holdings Inc’s EPS increase for this current 12-month fiscal period is 10.00% and is forecasted to reach -0.84 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 15.21% through the next 5 years, which can be compared against the 4.78% growth it accomplished over the previous five years trading on the market.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
Let’s observe the current performance indicators for Rani Therapeutics Holdings Inc (RANI). It’s Quick Ratio in the last reported quarter now stands at 0.88. The Stock has managed to achieve an average true range (ATR) of 0.13. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 26.70.
In the same vein, RANI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.98, a figure that is expected to reach -0.26 in the next quarter, and analysts are predicting that it will be -0.84 at the market close of one year from today.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
Now, what If we examine the latest scores posted by [Rani Therapeutics Holdings Inc, RANI]. During the last 5-days, its volume was better the volume of 0.76 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 6.69% While, its Average True Range was 0.1363.
Raw Stochastic average of Rani Therapeutics Holdings Inc (RANI) in the period of the previous 100 days is set at 6.60%, which indicates a major fall in contrast to 13.59% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 161.55% that was higher than 105.88% volatility it exhibited in the past 100-days period.
